Agf Investments LLC Sarepta Therapeutics, Inc. Transaction History

Agf Investments LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$63.15 - $90.42 $626,574 - $897,147	-9,922 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$77.28 - $99.42 $151,005 - $194,266	1,954 Added 24.52%	9,922 $893,000
Q3 2021 Nov 10, 2021	SELL	$65.97 - $92.48 $11,214 - $15,721	-170 Reduced 2.09%	7,968 $737,000
Q2 2021 Aug 12, 2021	BUY	$69.38 - $86.75 $564,614 - $705,971	8,138 New	8,138 $633,000
Q1 2019 May 13, 2019	SELL	$106.67 - $151.68 $139,844 - $198,852	-1,311 Closed	0 $0

Q4 2018 Feb 08, 2019	BUY	$97.32 - $148.76 $30,266 - $46,264	311 Added 31.1%	1,311 $143,000
Q3 2018 Nov 07, 2018	BUY	$115.31 - $161.51 $115,310 - $161,510	1,000 New	1,000 $162,000

470

79.3M

4.23M

1.21M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $13.5B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Agf Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Agf Investments LLC with notifications on news.